Jesper B Andersen
Københavns Universitet
H-index: 52
Europe-Denmark
Top articles of Jesper B Andersen
Title | Journal | Author(s) | Publication Date |
|---|---|---|---|
Molecular portraits of patients with intrahepatic cholangiocarcinoma who diverge as rapid progressors or long survivors on chemotherapy | Gut | Colm J O'Rourke Massimiliano Salati Colin Rae Guido Carpino Holly Leslie | 2024/3/1 |
Multimodal single-cell profiling reveals cancer crosstalk between macrophages and stromal cells in poor prognostic cholangiocarcinoma patients | bioRxiv | Lara Heij Sikander Hayat Konrad Reichel Sidrah Maryam Colm J O’Rourke | 2024/2/7 |
Role of ganglioside GD2 in the stem-like compartment of intrahepatic cholangiocarcinoma | Digestive and Liver Disease | A Mannini M Pastore M Correnti T Lottini B Piombanti | 2024/2/1 |
Hepatocellular Carcinoma Overcomes Lipid Depletion by Utilizing Serine for Phospholipid Synthesis and Enhanced Survival | Jesper Andersen Monika Lewinska Juan Lafuente-Barquero Mikel Ruiz de Gauna Xabier Buqué | 2024/1/10 | |
Criteria for preclinical models of cholangiocarcinoma: scientific and medical relevance | Diego F Calvisi Luke Boulter Javier Vaquero Anna Saborowski Luca Fabris | 2023/7 | |
MicroRNA-27a-3p targets FoxO signalling to induce tumour-like phenotypes in bile duct cells | Journal of hepatology | Lea Duwe Patricia Munoz-Garrido Monika Lewinska Juan Lafuente-Barquero Letizia Satriano | 2023/2/1 |
Alternative promoters in CpG depleted regions are prevalently associated with epigenetic misregulation of liver cancer transcriptomes | Nature Communications | Chirag Nepal Jesper B Andersen | 2023/5/11 |
MerTK-expressing macrophages promote the malignant features of cholangiocarcinoma cells | Digestive and Liver Disease | M Pastore Ö Gönül Geyik J Andersen M Lewinska A Lleo | 2023/9/1 |
Immunogenomics of cholangiocarcinoma | Virag Gehl Colm J O’Rourke Jesper B Andersen | 2023/11/16 | |
Liquid biopsy protein biomarkers of cholangiocarcinoma risk, early diagnosis and survival mirroring tumor cells | Ainhoa Lapitz Mikel Azkargorta Piotr Milkiewicz Paula Olaizola Ekaterina Zhuravleva | 2023 | |
P17. 08. A CLINICAL AND MOLECULAR CHARACTERIZATION OF EXTRACRANIAL METASTASES IN GLIOBLASTOMAS | J Jacobsen C O'Rourke A Locallo J Carlsen J Ewald | 2023/9/1 | |
Novel insights on the contribution of collagen degradative macrophages to fibrosis resolution | María Fernández-Fernández Paloma Ruiz-Blázquez Valeria Pistorio Celia Martínez-Sánchez Michele Costanzo | 2023/6/21 | |
Genetic and epigenetic analysis of hepatocellular adenomas with atypical morphological features | Histopathology | Simon Haefliger Juergen Hench Colm J O'Rourke Nathalie Meyer‐Schaller Sarp Uzun | 2023/4 |
Protease-driven lysosomal activity is a core mechanism for macrophage driven collagen remodeling during liver and kidney fibrosis | Paloma Ruiz-Blázquez María Fernández-Fernández Valeria Pistorio Celia Martínez-Sánchez Michele Costanzo | 2023/10/26 | |
Preoperative immunological plasma markers TRAIL, CSF1 and TIE2 predict survival after resection for biliary tract cancer | Frontiers in Oncology | Hannes Jansson Martin Cornillet Dan Sun Iva Filipovic Christian Sturesson | 2023/6/19 |
Serum lipidome unravels a diagnostic potential in bile acid diarrhoea | Gut | Monika Lewinska Martin Lund Kårhus Anne-Marie Gade Ellegaard Manuel Romero-Gómez Rocio IR Macias | 2023/9/1 |
Combined Inhibition of Smoothened and the DNA Damage Checkpoint WEE1 Exerts Antitumor Activity in Cholangiocarcinoma | Molecular Cancer Therapeutics | Giulia Anichini Chiara Raggi Mirella Pastore Laura Carrassa Luisa Maresca | 2023/3/2 |
Therapeutic potential of targeting protein hyper-SUMOylation in cholangiocarcinoma | Journal of Hepatology | Paula Olaizola Irene Olaizola Marta Fernandez de Ara Maite G Fernandez-Barrena Laura Alvarez | 2023/6/1 |
115P Inhibition of KLF5 reduces tumor growth and sensitizes to chemotherapy-induced cell death in experimental models of cholangiocarcinoma | Annals of Oncology | A Landa Magdalena PM Rodrigues O Erice NA Paiva MG Fernandez-Barrena | 2023/10/1 |
Contribution of GD2 ganglioside to aggressivness of human cholangiocarcinoma | Digestive and Liver Disease | A Mannini C Raggi M Correnti E Rovida M Aureli | 2023/3/1 |
Co-Authors
